Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344

Detalles Bibliográficos
Autores principales: Zheng, Haosheng, Long, Guojie, Zheng, Yuzhen, Yang, Xingping, Cai, Weijie, He, Shiyun, Qin, Xianyu, Liao, Hongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913489/
https://www.ncbi.nlm.nih.gov/pubmed/36765955
http://dx.doi.org/10.3390/cancers15030586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913489/
https://www.ncbi.nlm.nih.gov/pubmed/36765955
http://dx.doi.org/10.3390/cancers15030586

Ejemplares similares